TABLE 2.
Summary of treatment planning data for organs at risk, in the FB plan and DIBH plan, respectively.
Dose | DIBH | FB | p value |
Heart | |||
Mean (Gy) | 3.6 ± 0.9 | 5.4 ± 1.6 | <0.01 |
D2% (Gy) | 13.4 ± 4.7 | 19.3 ± 6.1 | <0.01 |
V5 (%) | 15.9 ± 9.0 | 24.1 ± 8.6 | <0.01 |
V10 (%) | 4.3 ± 2.7 | 8.7 ± 5.0 | <0.01 |
LAD coronary artery | |||
Mean (Gy) | 3.9 ± 1.1 | 6.9 ± 1.8 | <0.01 |
V10 (%) | 6.4 ± 5.9 | 15.2 ± 9.7 | <0.01 |
D2% (Gy) | 9.0 ± 1.9 | 19.5 ± 5.8 | <0.01 |
Left lung | |||
Mean (Gy) | 9.5 ± 1.3 | 11.3 ± 1.3 | <0.01 |
D2% (Gy) | 44.9 ± 3.4 | 45.5 ± 3.2 | >0.05 |
V5 (%) | 42.5 ± 6.0 | 49.3 ± 5.0 | <0.01 |
V10 (%) | 27.1 ± 4.4 | 32.0 ± 4.3 | <0.01 |
V20 (%) | 16.5 ± 2.6 | 19.5 ± 3.0 | <0.01 |
Right lung | |||
Mean (Gy) | 1.6 ± 0.6 | 2.1 ± 1.1 | <0.01 |
V5 (%) | 3.9 ± 3.0 | 7.3 ± 4.2 | <0.01 |
Right breast | |||
Mean (Gy) | 2.1 ± 0.7 | 2.6 ± 1.0 | <0.01 |
V5 (%) | 5.8 ± 4.4 | 11.1 ± 5.0 | <0.01 |